A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Urinary Bladder Neoplasms · Non-Muscle Invasive Bladder Neoplasms · Carcinoma in Situ

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Michael G Oefelein Clinical Trials ( Site 0138), Bakersfield, California, United States

    Study coordinator · 661-310-1063
  • Genesis Research, LLC ( Site 0141), Los Alamitos, California, United States

  • USC Norris Comprehensive Cancer Center ( Site 0123), Los Angeles, California, United States

    Study coordinator · 800-872-2273
  • Genesis Healthcare-Torrance ( Site 0140), Torrance, California, United States

    Study coordinator · 310-542-0199
  • Genesis Research LLC ( Site 0118), Torrance, California, United States

    Study coordinator · 310-534-8400
  • Urology Associates ( Site 0144), Littleton, Colorado, United States

    Study coordinator · 303-733-8848
  • Urological Research Network ( Site 0133), Hialeah, Florida, United States

    Study coordinator · 786-431-2014
  • Associated Urological Specialists - Chicago Ridge ( Site 0139), Chicago Ridge, Illinois, United States

    Study coordinator · 708-566-6983
  • Southern Urology, LLC ( Site 0145), Lafayette, Louisiana, United States

    Study coordinator · 337-233-6665
  • University of Missouri Health Care ( Site 0126), Columbia, Missouri, United States

    Study coordinator · 573-882-7026
  • NHO Revive Research Institute, LLC ( Site 0137), Lincoln, Nebraska, United States

    Study coordinator · 402-484-4900
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0111), New York, New York, United States

    Study coordinator · 646-960-1012
  • TriState Urologic Services PSC Inc. dba The Urology Group ( Site 0122), Cincinnati, Ohio, United States

    Study coordinator · 513-841-7700
  • OHSU Knight Cancer Institute - South Waterfront ( Site 0110), Portland, Oregon, United States

    Study coordinator · 503-494-4779
  • MidLantic Urology ( Site 0102), Bala-Cynwyd, Pennsylvania, United States

    Study coordinator · 610-667-0458
  • The Conrad Pearson Clinic ( Site 0143), Germantown, Tennessee, United States

    Study coordinator · 901-236-0957
  • Texas Oncology-Austin Central ( Site 0107), Austin, Texas, United States

    Study coordinator · 512-421-4235
  • Urology Austin, PLLC ( Site 0109), Austin, Texas, United States

    Study coordinator · 512-410-3773
  • Urology of Virginia ( Site 0125), Virginia Beach, Virginia, United States

    Study coordinator · 757-457-5100
  • University of Washington - Fred Hutchinson Cancer Center ( Site 0100), Seattle, Washington, United States

    Study coordinator · 206-598-3300
  • Hospital Italiano de Buenos Aires ( Site 0307), CABA, Buenos Aires, Argentina

    Study coordinator · 541149590200
  • Instituto Alexander Fleming ( Site 0306), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

    Study coordinator · 5491153288346
  • Instituto de Investigaciones Clinicas Mar de Plata ( Site 0305), Mar del Plata, Buenos Aires, Argentina

    Study coordinator · +542234963224
  • Asociación de Beneficencia Hospital Sirio Libanés ( Site 0303), Buenos Aires, Buenos Aires F.D., Argentina

    Study coordinator · +541145740870
  • Fundacion Estudios Clinicos ( Site 0304), Rosario, Santa Fe Province, Argentina

    Study coordinator · +5403412221472
  • Sanatorio Parque ( Site 0300), Rosario, Santa Fe Province, Argentina

    Study coordinator · +543414268409
  • Fundación CORI para la Investigación y Prevención del Cáncer ( Site 0301), La Rioja, Argentina

    Study coordinator · 543804425438
  • Macquarie University ( Site 1801), Macquarie University, New South Wales, Australia

    Study coordinator · +61298122968
  • Fiona Stanley Hospital ( Site 1803), Perth, Western Australia, Australia

    Study coordinator · +61861511130
  • Instituto do Câncer e Transplante de Curitiba ( Site 0402), Curitiba, Paraná, Brazil

    Study coordinator · +5541992057755
  • Hospital de Clínicas de Passo Fundo ( Site 0406), Passo Fundo, Rio Grande do Sul, Brazil

    Study coordinator · 55 54 981271411
  • Fundação Pio XII - Hospital de Câncer de Barretos ( Site 0400), Barretos, São Paulo, Brazil

    Study coordinator · +5517996782301
  • Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0410), São Jose Do Rio Preto, São Paulo, Brazil

    Study coordinator · 551732015054
  • The Moncton Hospital-Oncology ( Site 0200), Moncton, New Brunswick, Canada

    Study coordinator · 5068574780
  • Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Univer ( Site 0204), Sherbrooke, Quebec, Canada

    Study coordinator · 8193461110
  • Oncocentro Valdivia ( Site 0507), Valdivia, Los Ríos Region, Chile

    Study coordinator · +56958537020
  • FALP ( Site 0500), Santiago, Region M. de Santiago, Chile

    Study coordinator · 56224218596
  • Pontificia Universidad Catolica de Chile ( Site 0502), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56223543334
  • Bradfordhill ( Site 0501), Santiago, Region M. de Santiago, Chile

    Study coordinator · +562 29490970
  • ONCOCENTRO APYS ( Site 0505), Viña del Mar, Valparaiso, Chile

    Study coordinator · +56985719699
  • Bradford Hill Norte ( Site 0503), Antofagasta, Chile

    Study coordinator · +56442023631
  • Instituto de Cancerología ( Site 0600), Medellín, Antioquia, Colombia

    Study coordinator · 57 604 3421010x5461
  • Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia-Center Investigator ( Site 0603), Bogotá, Bogota D.C., Colombia

    Study coordinator · +573016254437
  • IMAT S.A.S ( Site 0601), Montería, Departamento de Córdoba, Colombia

    Study coordinator · +576047862333
  • Oncólogos del Occidente S.A.S. - Sede Pereira ( Site 0604), Pereira, Risaralda Department, Colombia

    Study coordinator · +573002558656
  • Clínica Imbanaco S.A.S ( Site 0602), Cali, Valle del Cauca Department, Colombia

    Study coordinator · +576023851000
  • Herlev and Gentofte Hospital ( Site 3101), Herlev, Capital Region, Denmark

    Study coordinator · +4538683868
  • CHU Dijon Bourgogne ( Site 0802), Dijon, Cote-d Or, France

    Study coordinator · +33380295753
  • Bordeaux University Hospital - Pellegrin ( Site 0806), Bordeaux, Gironde, France

    Study coordinator · +33556795547
  • CHU de Rouen- urology ( Site 0803), Rouen, Haute-Normandie, France

    Study coordinator · +33 2 32 88 89 90
  • Hôpital Foch-Urology department ( Site 0801), Suresnes, Hauts-de-Seine, France

    Study coordinator · +33146252040
  • Hôpital Saint-Louis ( Site 0807), Paris, Île-de-France Region, France

    Study coordinator · +33142499620
  • Klinikum Stuttgart - Katharinenhospital ( Site 0909), Stuttgart, Baden-Wurttemberg, Germany

    Study coordinator · +4971127854720
  • Klinikum der Universität München Großhadern ( Site 0910), Munich, Bavaria, Germany

    Study coordinator · +4989440072268
  • Marienhospital Herne ( Site 0907), Herne, North Rhine-Westphalia, Germany

    Study coordinator · +4923234990
  • Universitaetsklinikum Halle ( Site 0902), Halle, Saxony-Anhalt, Germany

    Study coordinator · +49 345 557 5810
  • Universitaetsklinikum Jena ( Site 0903), Jena, Thuringia, Germany

    Study coordinator · +49 3641 9329901
  • Henry Dunant Hospital ( Site 1005), Athens, Attica, Greece

    Study coordinator · 0030 2106972246
  • Metropolitan General Hospital ( Site 1001), Athens, Attica, Greece

    Study coordinator · 0030 2106502831
  • ATTIKON GENERAL UNIVERSITY HOSPITAL ( Site 1000), Chaidari/Athens, Attica, Greece

    Study coordinator · 0030 2105832549
  • European Interbalkan Medical Center-Oncology Department ( Site 1008), Thessaloniki, Greece

    Study coordinator · 0030 2310400213
  • Szegedi Tudomanyegyetem ( Site 1113), Szeged, Csongrád megye, Hungary

    Study coordinator · +3662545404
  • Gyor- Moson- Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz ( Site 1116), Győr, Győr-Moson-Sopron, Hungary

    Study coordinator · + 36 96 507 900
  • Heves Vármegyei Markhot Ferenc Oktatókórház és Rendelőintézet ( Site 1118), Eger, Heves County, Hungary

    Study coordinator · +3636411444/3802
  • Szabolcs-Szatmar-Bereg Varmegyei Oktatokorhaz Nyiregyhazi Josa Andras Tagkorhaza ( Site 1117), Nyíregyháza, Szabolcs-Szatmár-Bereg, Hungary

    Study coordinator · +36 42 599 700
  • Debreceni Egyetem Klinikai Kozpont ( Site 1112), Debrecen, Hungary

    Study coordinator · +3652255256
  • Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 1202), Milan, Lombardy, Italy

    Study coordinator · 003902.2390 4450
  • Istituto Nazionale Tumori Regina Elena ( Site 1201), Rome, Roma, Italy

    Study coordinator · 003906 588961
  • Azienda USL 8 di Arezzo ( Site 1203), Arezzo, Italy

    Study coordinator · 00390575255434
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 1200), Roma, Italy

    Study coordinator · 0039 06 3015.7080
  • Rijnstate ( Site 1307), Arnhem, Gelderland, Netherlands

    Study coordinator · +31880058124
  • Erasmus MC ( Site 1300), Rotterdam, South Holland, Netherlands

    Study coordinator · +31 10 7041566
  • Oncosalud ( Site 0701), Lima, Lima Province, Peru

    Study coordinator · +515137900
  • IPOR Instituto Peruano de Oncología & Radioterapia ( Site 0702), San Isidro, Lima region, Peru

    Study coordinator · +512241598
  • Hospital Militar Central Luis Arias Schereiber ( Site 0700), Lima, Peru

    Study coordinator · +51997468543
  • Clinical Research Center Spółka z ograniczoną odpowiedzialnością MEDIC-R Sp.k ( Site 1402), Poznan, Greater Poland Voivodeship, Poland

    Study coordinator · +48 500 799 053
  • Szpital Wojewódzki im. Świętego Lukasza SP ZOZ w Tarnowie ( Site 1404), Tarnów, Lesser Poland Voivodeship, Poland

    Study coordinator · +48146315000
  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworów Układu Moczowego ( Site 1401), Warszawa, Lesser Poland Voivodeship, Poland

  • Hospital Universitari Parc Tauli ( Site 1505), Sabadell, Barcelona, Spain

    Study coordinator · +34937240084
  • Hospital Insular de Gran Canaria ( Site 1502), Las Palmas de Gran Canaria, Canary Islands, Spain

    Study coordinator · +34928441738
  • Hospital Clinico San Carlos... ( Site 1500), Madrid, Spain

    Study coordinator · +34913303000
  • Hospital Universitario 12 de Octubre ( Site 1507), Madrid, Spain

    Study coordinator · +34913908121
  • HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID ( Site 1506), Madrid, Spain

    Study coordinator · +34914521987
  • Hospital Universitario Virgen Macarena ( Site 1504), Seville, Spain

    Study coordinator · +3495500800
  • Bangkok Metropolitan Administration Medical College and Vajira Hospital ( Site 3002), Dusit, Bangkok, Thailand

    Study coordinator · +6622443522
  • Faculty of Medicine - Khon Kaen University ( Site 3001), Muang, Changwat Khon Kaen, Thailand

    Study coordinator · +6643363746
  • Gartnavel General Hospital ( Site 1702), Glasgow, Glasgow City, United Kingdom

    Study coordinator · +441413017000
  • St Bartholomew s Hospital ( Site 1700), London, London, City of, United Kingdom

    Study coordinator · +4402073777000
  • Torbay Hospital ( Site 1701), Torquay, United Kingdom

    Study coordinator · +441803614567
מובילי המחקר
  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC